trending Market Intelligence /marketintelligence/en/news-insights/trending/4B-VOSjtdJcKrO5ZZ6eWdA2 content esgSubNav
In This List

Allena Pharmaceuticals plans $92M IPO

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


Allena Pharmaceuticals plans $92M IPO

Allena Pharmaceuticals Inc. plans to raise $92 million through an initial public offering of common stock.

The Newton, Mass.-based biotech company granted underwriters a 30-day option to buy additional common shares at the offering price.

According to its prospectus, Allena Pharmaceuticals applied to list the shares on the Nasdaq Global Market under the symbol ALNA.

Credit Suisse Securities (USA) LLC, Jefferies LLC, Cowen and Co. LLC and Wedbush Securities Inc. are acting as underwriters for the offering.